Norman Reilly III (Trey) focuses his practice on the representation of issuers and underwriters across a variety of public and private capital markets transactions, including initial public offerings and other equity offerings, high-yield and investment-grade debt offerings, tender offers and more. Trey also regularly advises public companies with respect to compliance with the US securities laws and other corporate governance matters.

Download full bio 


  • CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion 

  • Xometry – $287 Million Convertible Senior Notes Offering 

  • CS Disco – $246 Million IPO 

  • Xometry – $348 Million IPO 

  • Finch Therapeutics – $128 Million IPO 

  • View all


  • Duke University School of Law
    JD, magna cum laude, 2015

  • Fordham University
    BS, Business Administration
    magna cum laude, 2012

Admissions & Credentials

New York